Sharepoint Solutions
PRODUCTS
-
![MyPharmeva]( "Modern ePRO/eCOA: Craft A Unified Digital Patient Experience")
It’s about time.
Modern ePRO/eCOA.
Solved.Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
-
![GettyImages-1189302612 doctor]( "Regulatory Sciences")
We want your product to move through the regulatory process, gaining approvals and ultimately helping patients. Using our industry leading knowledge and skills, we will meet you where you are – gaining approval: for the first in human trials, in development, at scientific advice, at the end of phase 2, or post approval. At every level, our scientific expertise and in-depth knowledge of therapeutic backgrounds have guided every client we have to a successful outcome.
-
![GettyImages-1059548518 global conntection]( "Getting Biotechs GlobalReady")
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
![GettyImages-1295294256 doctor phone data]( "TrialKit eConsent")
Help your patients make informed decisions without burying them in paper
With electronic informed consent (eConsent) software, your patients can access consent forms using any device they choose. And because it’s part of TrialKit’s unified platform, both your patients and your study team get a seamless experience.
-
![GettyImages-597971944-viral-vector-AAV-adeno-associated-virus]( "Our Capabilities")
Expediting the customer journey from discovery all the way through commercial release.
WHITE PAPERS AND CASE STUDIES
-
![Scientist Using Pipette GettyImages-1140779660]( "Cell Line Development: The Linchpin In Biotherapeutic Development")
Cell Line Development: The Linchpin In Biotherapeutic DevelopmentReview key factors for building a reliable CLD strategy, and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.
-
![GettyImages-2148124393 DNA]( "A Risk-Based Approach To Plasmid DNA And mRNA Process Development")
A Risk-Based Approach To Plasmid DNA And mRNA Process DevelopmentBalancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
![GettyImages-1341292033-tablet-cleanroom-equipment-protective-gloves]( "Cleanroom Recovery. Proven Results. Contamination Control Case Studies")
Cleanroom Recovery. Proven Results. Contamination Control Case StudiesThrough this collection, review how a proven, automated solution can help facilities stay compliant, operational, and protected — whether in a crisis or during planned maintenance.
-
![Outsourcing Business Human Resources--GettyImages-1305829382]( "Enabling CDMOs To Focus On Core Priorities")
Enabling CDMOs To Focus On Core PrioritiesExplore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
![GettyImages-2223536069 protein]( "Development Of A Non-Standard Protein Therapeutic")
Development Of A Non-Standard Protein TherapeuticDiscover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
![pediatrics iStock-1193306596]( "Early-Stage Development In Rare Pediatric Oncology")
Early-Stage Development In Rare Pediatric OncologyLearn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
![Business meeting-GettyImages-1317387050]( "How Syneos Health Tackles Protocol Complexities")
How Syneos Health Tackles Protocol ComplexitiesExplore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.
-
![Pharmaceutical Tablets GettyImages-610221624]( "Overcoming Known Pharmacological Effects")
Overcoming Known Pharmacological EffectsUncover how our team was able to address the challenges of evaluating treatments that reduce food consumption and cause body weight loss while ensuring animal health and study integrity.
-
![Expanding Diabetes-Related Eye Health Equity]( "Expanding Diabetes-Related Eye Health Equity")
Expanding Diabetes-Related Eye Health Equity20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.
-
![Scientist Using Computer In Lab GettyImages-1370154322]( "Antibody Coverage Analysis Of E. coli HCPs In The BL21(DE3) Strain")
Antibody Coverage Analysis Of E. coli HCPs In The BL21(DE3) StrainReview a study conducted to determine the suitability and similarity of Cygnus E. coli HCP ELISA Kits to quantify BL21(DE3) Host Cell Proteins (HCPs).
-
![GettyImages-1294319145 breast cancer]( "The Latest Trends In The Prevention And Treatment Of Cervical Cancer")
The Latest Trends In The Prevention And Treatment Of Cervical CancerWhat immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?
-
![Nurse-covid vaccine-GettyImages-1322616160]( "Patient-Defined Recruitment: The Movement Advanced By COVID-19")
Patient-Defined Recruitment: The Movement Advanced By COVID-19The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.
NEWS
-
Kruger Products Inaugurates New LDC Plant In Sherbrooke6/9/2025
Kruger Products Inc. today inaugurated its new LDC (light dry crepe) tissue plant in Sherbrooke, constructed on a site adjacent to its TAD plant.
-
Advancing Regional Polio Vaccine Production With Fixed-Bed Bioreactor Technology4/9/2025
Batavia Biosciences, a leading contract development and manufacturing organization (CDMO), has pioneered a novel upstream bioprocessing method to enhance regional polio vaccine production.
-
WRF Seeks Pre-Proposals For High-Priority Utility Research1/15/2026
The Water Research Foundation (WRF) is now accepting pre-proposals for its matching research program, the Tailored Collaboration Program.
-
Rapeseed Protein For Vegan Burger Patties And Nutritious Chicken Feed8/13/2025
Food products containing proteins from plants, fungi or algae are becoming increasingly popular. Researchers at the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, Germany, have now shown that previously rarely used rapeseed proteins are also a valuable source of protein alternatives: using the EthaNa process, they extract not only high-quality rapeseed oil from rapeseed but also a protein-rich rapeseed kernel concentrate, which can be processed for instance into burger patties and pasta or used as a nutritious feed in poultry fattening.
-
'A More Versatile And Powerful Foundation For Future Photonic Technologies'6/24/2025
The candidate pool for engineered materials that can help enable tomorrow’s cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.